Targeted Action and Financing the Fight Against Antimicrobial Resistance in Asia
Antimicrobial Resistance (AMR) is not just a looming health crisis - it is already a deadly reality, demanding urgent and coordinated global action. The Centre for Impact Investing and Practices, in collaboration with the World Economic Forum's Giving to Amplify Earth Action (GAEA) initiative, supported by the Philanthropy Asia Alliance (PAA), developed a study on the threat of AMR in Asia with the following objectives:
1. To explore the multi-faceted social, economic, and environmental factors contributing to AMR in Asia's healthcare and agriculture sectors.
2. To identify shortfalls in financing in clinical development and healthcare systems that can be alleviated by private and catalytic capital.
3. To create a compelling case for collaborative action among investors, philanthropists, and companies, by outlining actionable strategies and financing models that can supercharge the fight against AMR.
The report draws from global disease burden data to illustrate the impact of the silent, growing pandemic of AMR, and highlights how a unique combination of healthcare, agriculture, and water, sanitation and hygiene (WASH) makes Asia the perfect crucible for the spread of AMR. The report also includes insights from 15 case studies and examples of funding mechanisms, and showcases how the fight against AMR requires a multisystem approach across One Health actors focusing on education, prevention, monitoring, and treatment. Ultimately, everyone has a part to play in addressing AMR in our region.
Download the report here.